Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?
J Clin Med
; 11(9)2022 Apr 22.
Article
em En
| MEDLINE
| ID: mdl-35566471
ABSTRACT
The purpose of this review is to summarize the current knowledge on lymph node dissection (LND) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP). Despite a growing body of evidence, the utility and therapeutic and prognostic value of such an approach, as well as the optimal extent of LND, remain unsolved issues. Although LND is the most accurate staging procedure, the direct therapeutic effect is still not evident from the current literature, which limits the possibility of establishing clear recommendations. This indicates the need for further robust and adequately designed high-quality clinical trials.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Revista:
J Clin Med
Ano de publicação:
2022
Tipo de documento:
Article